TY - JOUR
T1 - Risk prediction for 30-day heart failure-specific readmission or death after discharge
T2 - Data from the Korean Acute Heart Failure (KorAHF) registry
AU - Lim, Nam Kyoo
AU - Lee, Sang Eun
AU - Lee, Hae Young
AU - Cho, Hyun Jai
AU - Choe, Won Seok
AU - Kim, Hokon
AU - Choi, Jin Oh
AU - Jeon, Eun Seok
AU - Kim, Min Seok
AU - Kim, Jae Joong
AU - Hwang, Kyung Kuk
AU - Chae, Shung Chull
AU - Baek, Sang Hong
AU - Kang, Seok Min
AU - Choi, Dong Ju
AU - Yoo, Byung Su
AU - Kim, Kye Hun
AU - Cho, Myeong Chan
AU - Oh, Byung Hee
AU - Park, Hyun Young
N1 - Funding Information:
This study was performed under the Korea National Institute of Health intramural research grant 4800-4845-300-210-13 (2016-NI63001-00).
Publisher Copyright:
© 2018 The Authors
PY - 2019/2
Y1 - 2019/2
N2 - Background: Identifying patients with acute heart failure (HF) at high risk for readmission or death after hospital discharge will enable the optimization of treatment and management. The objective of this study was to develop a risk score for 30-day HF-specific readmission or death in Korea. Methods: We analyzed the data from the Korean Acute Heart Failure (KorAHF) registry to develop a risk score. The model was derived from a multiple logistic regression analysis using a stepwise variable selection method. We also proposed a point-based risk score to predict the risk of 30-day HF-specific readmission or death by simply summing the scores assigned to each risk variable. Model performance was assessed using an area under the receiver operating characteristic curve (AUC), the Hosmer–Lemeshow goodness-of-fit test, the net reclassification improvement (NRI), and the integrated discrimination improvement (IDI) index to evaluate discrimination, calibration, and reclassification, respectively. Results: Data from 4566 patients aged ≥40 years were included in the analysis. Among them, 446 (9.8%) had 30-day HF-specific readmission or death. The final model included 12 independent variables (age, New York Heart Association functional class, clinical history of hypertension, HF admission, chronic obstructive pulmonary disease, etiology of cardiomyopathy, systolic blood pressure, left ventricular ejection fraction, serum sodium, brain natriuretic peptide, N-terminal prohormone of brain natriuretic peptide at discharge, and prescription of β-blockers and angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists at discharge). The point risk score showed moderate discrimination (AUC of 0.710; 95% confidence interval, 0.685–0.735) and good calibration (χ2 = 8.540, p = 0.3826). Conclusions: The risk score for the prediction of the risk of 30-day HF-specific readmission or death after hospital discharge was developed using 12 predictors. It can be utilized to guide appropriate interventions or care strategies for patients with HF.
AB - Background: Identifying patients with acute heart failure (HF) at high risk for readmission or death after hospital discharge will enable the optimization of treatment and management. The objective of this study was to develop a risk score for 30-day HF-specific readmission or death in Korea. Methods: We analyzed the data from the Korean Acute Heart Failure (KorAHF) registry to develop a risk score. The model was derived from a multiple logistic regression analysis using a stepwise variable selection method. We also proposed a point-based risk score to predict the risk of 30-day HF-specific readmission or death by simply summing the scores assigned to each risk variable. Model performance was assessed using an area under the receiver operating characteristic curve (AUC), the Hosmer–Lemeshow goodness-of-fit test, the net reclassification improvement (NRI), and the integrated discrimination improvement (IDI) index to evaluate discrimination, calibration, and reclassification, respectively. Results: Data from 4566 patients aged ≥40 years were included in the analysis. Among them, 446 (9.8%) had 30-day HF-specific readmission or death. The final model included 12 independent variables (age, New York Heart Association functional class, clinical history of hypertension, HF admission, chronic obstructive pulmonary disease, etiology of cardiomyopathy, systolic blood pressure, left ventricular ejection fraction, serum sodium, brain natriuretic peptide, N-terminal prohormone of brain natriuretic peptide at discharge, and prescription of β-blockers and angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists at discharge). The point risk score showed moderate discrimination (AUC of 0.710; 95% confidence interval, 0.685–0.735) and good calibration (χ2 = 8.540, p = 0.3826). Conclusions: The risk score for the prediction of the risk of 30-day HF-specific readmission or death after hospital discharge was developed using 12 predictors. It can be utilized to guide appropriate interventions or care strategies for patients with HF.
UR - http://www.scopus.com/inward/record.url?scp=85055103970&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055103970&partnerID=8YFLogxK
U2 - 10.1016/j.jjcc.2018.07.009
DO - 10.1016/j.jjcc.2018.07.009
M3 - Article
C2 - 30360893
AN - SCOPUS:85055103970
SN - 0914-5087
VL - 73
SP - 108
EP - 113
JO - Journal of Cardiology
JF - Journal of Cardiology
IS - 2
ER -